Simulations Plus Inc

Type: Company
Name: Simulations Plus Inc
First reported 17 hours ago - Updated 17 hours ago - 1 reports

Shares of Simulations Plus Receive a Boost, Up 2.1%

One of today's notable stocks on the rise is Simulations Plus (NASDAQ:SLP), up 2.1% to $6.90. The Dow Jones Industrial Average is now trading fractionally lower to 17,071 and the S&P is trading fractionally lower to 1,975. ... [Published Individual.com - 17 hours ago]
First reported Sep 19 2014 - Updated Sep 20 2014 - 1 reports

Uptrend Call Working As Simulations Plus Stock Rises 13.9% (SLP)

SmarTrend identified an Uptrend for Simulations Plus (NASDAQ:SLP) on August 5th, 2014 at $6.15. In approximately 2 month, Simulations Plus has returned 13.91% as of today's recent price of $7. ... [Published Individual.com - Sep 19 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 5 reports

Simulations Plus Wins Cooperative Agreement with FDA

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has been notified by the U.S. Food and…Click to Continue » ... [Published Fort Mills Times - Sep 15 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

11.5% Return Seen to Date on SmarTrend Simulations Plus Call (SLP)

SmarTrend identified an Uptrend for Simulations Plus (NASDAQ:SLP) on August 5th, 2014 at $6.15. In approximately 1 month, Simulations Plus has returned 11.47% as of today's recent price of $6.85. ... [Published Individual.com - Sep 12 2014]
First reported Sep 09 2014 - Updated Sep 10 2014 - 1 reports

Stock Investors Bid Up Shares of Simulations Plus, Up 1.8%

Up 1.8% to $6.63, Simulations Plus (NASDAQ:SLP), is one of today's notable movers. The Dow is down 0.4% to 17,037 and the S&P is currently down 0.4% to 1,994. ... [Published Individual.com - Sep 09 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Simulations Plus Reports Preliminary Revenues for Fourth Fiscal Quarter FY2014

LANCASTER, Calif.--( BUSINESS WIRE )--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fourth fiscal quarter and fiscal ... [Published Fierce Biotech IT - Sep 08 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 6 reports

Company Profile for Simulations Plus, Inc.

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by…Click to Continue » ... [Published Fort Mills Times - Sep 05 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

SIMULATIONS PLUS INC FILES (8-K) Disclosing Other Events

, Simulations Plus, Inc., a California corporation (the "Company"), issued a press release announcing preliminary revenues for its fourth quarter of fiscal year 2014 ended August 31, 2014, and for the fiscal year ended August 31, 2014. The press release ... [Published Town Hall - Sep 04 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 6 reports

Simulations Plus Q4 Revenues Up 15%

Simulations Plus Inc. (SLP: Quote), Thursday said its revenues for the fourth quarter increased 15.1 percent to $1.81 million from $1.57 million last year.About 25.5 percent of revenues came from new software licenses, while 5.5 percent of revenues came ... [Published RTTNews.com - Sep 04 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

Highest Operating Margin in the Health Care Technology Industry Detected in Shares of Simulations Plus (SLP, CERN, MDAS, OMCL, HSTM)

(Comtex SmarTrend(R)) Below are the three companies in the Health Care Technology industry with the highest operating margin. A healthy operating margin is required for a company to pay for its fixed costs and generate cash.Simulations Plus ranks highest ... [Published Individual.com - Sep 04 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

Briefs: Rexford, PennyMac Financial, Simulations Plus

Rexford Industrial Realty Inc. has purchased a 55,500-square-foot industrial building in San Fernando for $5.1 million.The L.A. real estate investment trust bought the property at 605 8th St. from an undisclosed seller and was funded by cash on hand, ... [Published San Fernando Valley Business Journal - Sep 04 2014]
First reported Sep 02 2014 - Updated Sep 03 2014 - 7 reports

Simulations Plus acquires Cognigen

(TELECOMWORLDWIRE via COMTEX) --Simulations Plus, Inc. (NASDAQ: SLP) said that the agreement and plan of merger with Cognigen Corp. of Buffalo, New York, has been closed and the two companies are now merged.Upon closing, Cognigen has become a wholly-owned ... [Published TradingCharts.com - Sep 03 2014]

Quotes

Mr John DiBella, vice president for marketing and sales for Simulations Plus, added, "This interim release of GastroPlus addresses a number of requested features that we wanted to deploy to our users as soon as possible rather than waiting for the next major release. Following our recently announced acquisition of Cognigen, this release also helps us realize one of our stated goals of expanding the use of our technology into clinical pharmacology groups, which we feel is a significant growth area for the company. GastroPlus continues to enjoy its industry-leading reputation for predictive accuracy. This release demonstrates our commitment to maximizing the productivity of our users at the earliest possible date."
Ted Grasela, newly appointed president of Simulations Plus, added: "I am very pleased to have been appointed president of Simulations Plus and Cognigen, and I'm encouraged by the strong preliminary results we are reporting today. I'm looking forward to fiscal year 2015 and working with the Simulations Plus and Cognigen teams to continue the excellent history of growth for Simulations Plus."
"I am pleased to be appointed President of the combined companies and I look forward to working with Walt and the board of directors to ensure the continued success of our company. I am excited about the opportunities this merger affords for the future of clinical pharmacology. The recent push by regulatory agencies to use physiologically based pharmacokinetics, a strength of Simulations Plus, in clinical pharmacology, a strength of Cognigen, makes the timing of this merger ideal."
Walt Woltosz , chairman and chief executive officer of Simulations Plus Inc. said, "This is an exciting step forward for both Simulations Plus and Cognigen. Dr. Thaddeus (" Ted") Grasela , the former President of Cognigen, has been appointed President of the combined companies and will join the board of directors to replace...

More Content

All (123) | News (28) | Reports (0) | Blogs (95) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Shares of Simulations Plus Receive a Boost, Up ... [Published Individual.com - 17 hours ago]
Uptrend Call Working As Simulations Plus Stock ... [Published Individual.com - Sep 19 2014]
Simulations Plus Wins Cooperative Agreement wit... [Published Fort Mills Times - Sep 15 2014]
Simulations Plus Wins Cooperative Agreement wit... [Published EON Business - Sep 15 2014]
Simulations Plus Wins Cooperative Agreement wit... [Published Business Wire Professional Services News - Sep 15 2014]
Simulations Plus Wins Cooperative Agreement wit... [Published Business Wire Technology News - Sep 15 2014]
Simulations Plus Wins Cooperative Agreement wit... [Published Business Wire Health News - Sep 15 2014]
11.5% Return Seen to Date on SmarTrend Simulati... [Published Individual.com - Sep 12 2014]
Stock Investors Bid Up Shares of Simulations Pl... [Published Individual.com - Sep 09 2014]
Simulations releases version 8.6 of GastroPlus ... [Published Individual.com - Sep 09 2014]
Simulations Plus Reports Preliminary Revenues f... [Published Fierce Biotech IT - Sep 08 2014]
Company Profile for Simulations Plus, Inc. [Published Fort Mills Times - Sep 05 2014]
Company Profile for Simulations Plus, Inc. [Published Business Wire Science: Science News - Sep 05 2014]
Company Profile for Simulations Plus, Inc. [Published Business Wire Technology News - Sep 05 2014]
Company Profile for Simulations Plus, Inc. [Published Business Wire Health News - Sep 05 2014]
Simulations Plus Purchases Cognigen [Published Individual.com - Sep 05 2014]
SIMULATIONS PLUS : Acquires Cognigen [Published 4 Traders - Sep 05 2014]
SIMULATIONS PLUS INC FILES (8-K) Disclosing Oth... [Published Town Hall - Sep 04 2014]
Simulations Plus Q4 Revenues Up 15% [Published RTTNews.com - Sep 04 2014]
Simulations Plus Reports Preliminary Revenues f... [Published Investor's Business Daily - Sep 04 2014]
Simulations Plus Reports Preliminary Revenues f... [Published EON Business - Sep 04 2014]
Simulations Plus Reports Preliminary Revenues f... [Published Business Wire Technology News - Sep 04 2014]
Simulations Plus Reports Preliminary Revenues f... [Published Business Wire Professional Services News - Sep 04 2014]
Simulations Plus Reports Preliminary Revenues f... [Published Business Wire Health News - Sep 04 2014]
Highest Operating Margin in the Health Care Tec... [Published Individual.com - Sep 04 2014]
Briefs: Rexford, PennyMac Financial, Simulation... [Published San Fernando Valley Business Journal - Sep 04 2014]
Simulations Plus acquires Cognigen [Published TradingCharts.com - Sep 03 2014]
Simulations Plus Inc closes acquisition of Cogn... [Published Reuters - Sep 02 2014]
Simulations Plus Closes Acquisition of Cognigen... [Published Fort Mills Times - Sep 02 2014]
Simulations Plus Closes Acquisition of Cognigen... [Published Morningstar.com - Sep 02 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Simulations Plus Wins Cooperative Agreement wit... [Published EON Business - Sep 15 2014]
LANCASTER, Calif.--(EON: Enhanced Online News)--Simulations Plus announced it has been awarded a $200,000 grant by the US FDA to cooperatively develop improved modeling and simulation capabilities for drugs designed to be applied to the eye. ...
Simulations Plus Wins Cooperative Agreement wit... [Published Business Wire Professional Services News - Sep 15 2014]
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced it has been awarded a $200,000 grant by the US FDA to cooperatively develop improved modeling and simulation capabilities for drugs designed to be applied to the eye. ...
Simulations Plus Wins Cooperative Agreement wit... [Published Business Wire Technology News - Sep 15 2014]
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced it has been awarded a $200,000 grant by the US FDA to cooperatively develop improved modeling and simulation capabilities for drugs designed to be applied to the eye. ...
Simulations Plus Wins Cooperative Agreement wit... [Published Business Wire Health News - Sep 15 2014]
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced it has been awarded a $200,000 grant by the US FDA to cooperatively develop improved modeling and simulation capabilities for drugs designed to be applied to the eye. ...
Company Profile for Simulations Plus, Inc. [Published Business Wire Science: Science News - Sep 05 2014]
--(BUSINESS WIRE)--Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, ...
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.